Pirfenidone inhibits TGF-β1-induced fibrosis via downregulation of Smad and ERK pathway in MDCK cells.

MLA

Im, Chae-Yoon, et al. “Pirfenidone Inhibits TGF-Β1-Induced Fibrosis via Downregulation of Smad and ERK Pathway in MDCK Cells.” Veterinary Research Communications, vol. 48, no. 5, Oct. 2024, pp. 3167–76. EBSCOhost, https://doi.org/10.1007/s11259-024-10493-y.

APA

Im, C.-Y., Kim, S.-H., Song, K.-H., Ryu, M.-O., Youn, H.-Y., & Seo, K.-W. (2024). Pirfenidone inhibits TGF-β1-induced fibrosis via downregulation of Smad and ERK pathway in MDCK cells. Veterinary Research Communications, 48(5), 3167–3176. https://doi.org/10.1007/s11259-024-10493-y

Chicago

Im, Chae-Yoon, Se-Hoon Kim, Ki-Hoon Song, Min-Ok Ryu, Hwa-Young Youn, and Kyoung-Won Seo. 2024. “Pirfenidone Inhibits TGF-Β1-Induced Fibrosis via Downregulation of Smad and ERK Pathway in MDCK Cells.” Veterinary Research Communications 48 (5): 3167–76. doi:10.1007/s11259-024-10493-y.